Evolent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolent Health, Inc. on March 27, 2017. The filing relates to the provision of unaudited pro forma financial information regarding the combined operations of Evolent Health, Inc. and Valence Health, Inc., excluding Cicerone Health Solutions, Inc., for the fiscal year ended December 31, 2016.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It solely references the existence of an exhibit containing the unaudited pro forma condensed combined statement of operations.
Material Changes
The filing discloses the preparation of pro forma financial statements to reflect the combined entity of Evolent Health and Valence Health. No specific quantitative material changes versus prior periods are detailed in the text of this report.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The document is limited to the disclosure of the pro forma financial exhibit.
Investor Verification Checklist
- Review Exhibit 99.1 for the specific unaudited pro forma condensed combined statement of operations for the year ended December 31, 2016.
- Verify the exclusion of Cicerone Health Solutions, Inc. from the combined financial data.
- Confirm the details of the transaction between Evolent Health and Valence Health in related filings to understand the context of the pro forma adjustments.